Effect of serotonin receptor 2A gene polymorphism on mirtazapine response in major depression (Q46722416)

24 December 2017

title

Effect of serotonin receptor 2A gene polymorphism on mirtazapine response in major depression (English)

1 reference

24 December 2017

0 references

5

Min-Soo Lee

1 reference

24 December 2017

author name string

Rhee-Hun Kang

1

1 reference

24 December 2017

Myoung-Jin Choi

2

1 reference

24 December 2017

Jong-Woo Paik

3

1 reference

24 December 2017

Sang-Woo Hahn

4

1 reference

24 December 2017

publication date

1 January 2007

1 reference

24 December 2017

International Journal of Psychiatry in Medicine

published in

1 reference

24 December 2017

volume

37

1 reference

24 December 2017

issue

3

1 reference

24 December 2017

page(s)

315-329

1 reference

24 December 2017

Monoamines and abnormal behaviour. A multi-aminergic perspective

cites work

1 reference

Tolerability and safety aspects of mirtazapine

21 January 2018

1 reference

The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study

21 January 2018

1 reference

Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone.

21 January 2018

1 reference

The human 5-HT2 receptor is encoded by a multiple intron-exon gene

21 January 2018

1 reference

Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine.

21 January 2018

1 reference

A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter.

21 January 2018

1 reference

Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene

21 January 2018

1 reference

Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression

21 January 2018

1 reference

Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder.

21 January 2018

1 reference

Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.

21 January 2018

1 reference

Investigation of serotonin-related genes in antidepressant response

21 January 2018

1 reference

Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.

21 January 2018

1 reference

Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder.

21 January 2018

1 reference

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

21 January 2018

1 reference

Polymorphisms in the 5-hydroxytryptamine 2A receptor and CytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in japanese depressed patients

21 January 2018

1 reference

Pharmacogenetics of antidepressant medication intolerance

21 January 2018

1 reference

Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram

21 January 2018

1 reference

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

21 January 2018

1 reference

No adjustments are needed for multiple comparisons

21 January 2018

1 reference

Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression

21 January 2018

1 reference

Onset of action of antidepressants: results of different analyses

21 January 2018

1 reference

Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients

21 January 2018

1 reference

Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine

21 January 2018

1 reference

Pharmacological characterization of the 5-HT receptors mediating contraction and relaxation of canine isolated proximal stomach smooth muscle

21 January 2018

1 reference

Serotonin-2 receptors and human sleep: effect of a selective antagonist on EEG power spectra.

21 January 2018

1 reference

LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine(2A) receptor antagonist: a comparison with the antidepressant, nefazodone

21 January 2018

1 reference

Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders

21 January 2018

1 reference

Differential expression of the "C" and "T" alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics

21 January 2018

1 reference

The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity

21 January 2018

1 reference

Brain 5-HT neurotransmission during paroxetine treatment.

21 January 2018

1 reference

Efficacy of antidepressants in the treatment of severe depression: the place of mirtazapine

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2190/PM.37.3.H

1 reference

24 December 2017

PubMed ID

18314859

1 reference

24 December 2017